Roger Song
Stock Analyst at Jefferies
(2.43)
# 3,013
Out of 5,051 analysts
270
Total ratings
37.6%
Success rate
0.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte | Reiterated: Buy | $146 | $70.65 | +106.65% | 9 | Oct 5, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $121 → $150 | $39.84 | +276.51% | 12 | Oct 1, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $704 | $550.10 | +27.98% | 18 | Oct 1, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $101 | $28.34 | +256.39% | 13 | Sep 23, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $125 | $23.91 | +422.79% | 19 | Sep 8, 2026 | |
| MANE Veradermics | Reiterated: Buy | $182 | $122.40 | +48.69% | 6 | Sep 8, 2026 | |
| REPL Replimune Group | Reiterated: Buy | $2 → $24 | $13.07 | +83.63% | 16 | Aug 17, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $48 | $11.33 | +323.65% | 4 | Aug 14, 2026 | |
| AVLN Avalyn Pharma | Reiterated: Buy | $52 | $24.80 | +109.68% | 2 | Aug 13, 2026 | |
| INO Inovio Pharmaceuticals | Upgraded: Buy | $1.8 → $3 | $1.11 | +171.49% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $133 | $80.35 | +65.53% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $21 | $5.94 | +253.54% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 | $55.27 | +50.17% | 6 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $371 → $474 | $332.07 | +42.74% | 3 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $22.16 | +103.07% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $2.83 | +288.69% | 1 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $2.13 | +87.79% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $71 | $79.24 | -10.40% | 6 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.40 | +614.29% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $3.28 | +448.78% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.79 | +682.12% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $2.42 | +561.16% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $42 | $10.05 | +317.91% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $154 | $60.48 | +154.63% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $10.40 | +169.36% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $6.87 | n/a | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $40 | $13.28 | n/a | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.36 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $17 | $0.2148 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $4 | $1.50 | n/a | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $52.02 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $2.56 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $0.4399 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.60 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $144.88 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.7902 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $1.90 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $2.62 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0003 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $26.40 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $25 | $12.66 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $3.38 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $14.46 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $29.43 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $3.74 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $134.38 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $1.06 | n/a | 1 | Apr 29, 2021 |
Vaxcyte
Oct 5, 2026
Reiterated: Buy
Price Target: $146
Current: $70.65
Upside: +106.65%
Nektar Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $121 → $150
Current: $39.84
Upside: +276.51%
United Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $704
Current: $550.10
Upside: +27.98%
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $101
Current: $28.34
Upside: +256.39%
Structure Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: $125
Current: $23.91
Upside: +422.79%
Veradermics
Sep 8, 2026
Reiterated: Buy
Price Target: $182
Current: $122.40
Upside: +48.69%
Replimune Group
Aug 17, 2026
Reiterated: Buy
Price Target: $2 → $24
Current: $13.07
Upside: +83.63%
Kailera Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $11.33
Upside: +323.65%
Avalyn Pharma
Aug 13, 2026
Reiterated: Buy
Price Target: $52
Current: $24.80
Upside: +109.68%
Inovio Pharmaceuticals
Aug 12, 2026
Upgraded: Buy
Price Target: $1.8 → $3
Current: $1.11
Upside: +171.49%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $133
Current: $80.35
Upside: +65.53%
Jul 31, 2026
Reiterated: Buy
Price Target: $62 → $21
Current: $5.94
Upside: +253.54%
Jul 14, 2026
Reiterated: Buy
Price Target: $83
Current: $55.27
Upside: +50.17%
Jul 13, 2026
Rated: Buy
Price Target: $371 → $474
Current: $332.07
Upside: +42.74%
Jul 8, 2026
Reiterated: Buy
Price Target: $45
Current: $22.16
Upside: +103.07%
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $2.83
Upside: +288.69%
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $2.13
Upside: +87.79%
Apr 28, 2026
Reiterated: Buy
Price Target: $58 → $71
Current: $79.24
Upside: -10.40%
Apr 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.40
Upside: +614.29%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $3.28
Upside: +448.78%
Mar 23, 2026
Reiterated: Buy
Price Target: $14
Current: $1.79
Upside: +682.12%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $2.42
Upside: +561.16%
Jan 22, 2026
Reiterated: Buy
Price Target: $13 → $42
Current: $10.05
Upside: +317.91%
Dec 19, 2025
Reiterated: Buy
Price Target: $154
Current: $60.48
Upside: +154.63%
Dec 10, 2025
Reiterated: Buy
Price Target: $28
Current: $10.40
Upside: +169.36%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $6.87
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: $80 → $40
Current: $13.28
Upside: n/a
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.36
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: $9 → $17
Current: $0.2148
Upside: n/a
Aug 20, 2025
Reiterated: Buy
Price Target: $12 → $4
Current: $1.50
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $52.02
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: $28
Current: $2.56
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $10 → $8
Current: $0.4399
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $7
Current: $3.60
Upside: n/a
Apr 10, 2025
Reiterated: Buy
Price Target: $68
Current: $144.88
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $0.7902
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $1.90
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $2.62
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.0003
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $26.40
Upside: n/a
Oct 16, 2024
Reiterated: Buy
Price Target: $31 → $25
Current: $12.66
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $3.38
Upside: n/a
Mar 27, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $14.46
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $29.43
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $3.74
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $134.38
Upside: n/a
Apr 29, 2021
Reiterated: Buy
Price Target: $23
Current: $1.06
Upside: n/a